Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|15|3|206-221

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.15, Iss.3, 2015-03, pp. : 206-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease

By  

Current Molecular Medicine, Vol. 3, Iss. 5, 2003-08 ,pp. : 447-458

Bentham Science Publishers

Access to resources Recommend Favorite

Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders

By  

Current Molecular Medicine, Vol. 15, Iss. 3, 2015-03 ,pp. : 275-295

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Targets in Cirrhotic Cardiomyopathy

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 21-26

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders

By  

Current Molecular Medicine, Vol. 15, Iss. 3, 2015-03 ,pp. : 253-264

Bentham Science Publishers

Access to resources Recommend Favorite

Adiponectin and its Receptors as Potential Therapeutical Targets

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 2, 2007-04 ,pp. : 107-114

Bentham Science Publishers

Access to resources Recommend Favorite